Based on our results, 89Zr-CD133 IgG provided information on celecoxib-induced downregulation of the colon cancer CD133 protein by displaying significantly decreased cell binding in vitro and reduced tumor uptake in vivo. The gene discussed is PROM1; the disease is malignant colon neoplasm.